Cell And Gene Therapy Clinical Trial Services Global Market Report 2025

Description

Cell and gene therapy clinical trial services are specialized offerings provided by contract research organizations (CROs) or clinical trial management firms to support the design, implementation, and oversight of clinical trials for cell and gene therapies. These services encompass various aspects such as protocol design, patient recruitment, regulatory compliance, and data management, ensuring precision, efficacy, and adherence to rigorous standards throughout the trial process.

The primary types of cell and gene therapy clinical trial services include clinical trial design and planning, supply chain and logistics management, regulatory affairs and compliance, data management and biostatistics, site management and monitoring, among others. Clinical trial design and planning entail the development and organization of trial protocols, determining the objectives and methodologies of the trial. Various types of therapies, including gene therapy, cell therapy, and gene-modified cell therapy, are utilized for a range of indications such as oncology, hematology, metabolic disorders, infectious diseases, neurology, cardiovascular diseases, musculoskeletal disorders, among others. These services cater to a diverse range of end-users, including pharmaceutical and biotechnology companies, contract research organizations, academic and research institutions, among others.

The cell and gene therapy clinical trial services market research report is one of a series of new reports from The Business Research Company that provides cell and gene therapy clinical trial services market statistics, including cell and gene therapy clinical trial services industry global market size, regional shares, competitors with a cell and gene therapy clinical trial services market share, detailed cell and gene therapy clinical trial services market segments, market trends and opportunities, and any further data you may need to thrive in the cell and gene therapy clinical trial services industry. This cell and gene therapy clinical trial services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cell and gene therapy clinical trial services market size has grown rapidly in recent years. It will grow from $3.79 billion in 2024 to $4.2 billion in 2025 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to the increased prevalence of chronic diseases, increased demand for effective treatments for rare genetic disorders, increased government funding for research in regenerative medicine, increased understanding of molecular mechanisms underlying various diseases, and increased awareness of the potential of personalized medicine.

The cell and gene therapy clinical trial services market size is expected to see rapid growth in the next few years. It will grow to $6.22 billion in 2029 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to increasing global incidence of genetic and auto-immune diseases, rising public and private sector funding for gene therapy research, growing adoption of novel technologies, and a rise in the number of genetic defects. Major trends in the forecast period include the adoption of AI, the adoption of machine learning, the adoption of personalized medicine, technological advancements, and gene therapies.

The increasing prevalence of genetic diseases is expected to drive the expansion of the cell and gene therapy clinical trial services market in the future. Genetic diseases result from variations in an individual's DNA or genetic makeup and are becoming more common due to factors such as increased accessibility to genetic testing, occurrences of genetic mutations, and the prevalence of consanguineous marriages. Cell and gene therapy clinical trial services play a crucial role in addressing the growing incidence of genetic diseases by fostering the development of innovative treatments, customizing therapies for individual patients, accelerating the translation of research into clinical applications, and broadening the treatment options available to patients with genetic disorders. For instance, according to the Cystic Fibrosis (CF) Foundation's July 2022 report, there has been a notable increase in the number of individuals diagnosed with cystic fibrosis, affecting nearly 40,000 children and adults in the United States alone, and over 105,000 people worldwide. Consequently, the rising prevalence of genetic diseases is a key driver behind the growth of the cell and gene therapy clinical trial services market.

Leading companies in the cell and gene therapy clinical trial services market are concentrating their efforts on introducing advanced technology, including customer relationship management (CRM) system technology, to enhance operational efficiency and gain a competitive advantage. CRM systems utilized by cell and gene therapy clinical trial services streamline and manage interactions with trial participants, healthcare providers, and other stakeholders throughout the clinical trial process. For instance, in April 2023, AmerisourceBergen Corporation unveiled the Cell and Gene Therapy (CGT) Integration Hub, a platform designed to enhance connectivity and streamline processes across the cell and gene therapy treatment pathway. Supported by AmerisourceBergen's CRM system, this platform aims to simplify care coordination by providing physicians and patient services teams with better visibility throughout the therapy development and delivery process. The CGT Integration Hub includes features such as expedited benefits investigation, real-time status tracking, and proactive alerts, all aimed at simplifying care coordination and improving the overall patient and provider experience in delivering cell and gene therapies.

In January 2024, Kyowa Kirin Co. Ltd. acquired Orchard Therapeutics Limited to strengthen its focus on addressing unmet medical needs in genetic and severe diseases by leveraging Orchard's expertise in developing and commercializing gene therapies for rare diseases. Orchard Therapeutics Limited, a UK-based biotechnology company, is dedicated to researching, developing, and commercializing gene therapies for rare diseases.

Major companies operating in the cell and gene therapy clinical trial services market are Thermo Fisher Scientific Inc., Sharp Services LLC, IQVIA, Laboratory Corporation of America Holdings, ICON plc, Syneos Health Inc., Catalent Pharma Solutions Inc., Charles River Laboratories International Inc., Parexel International Corporation, PRA Health Sciences Inc., Covance Inc., Medpace Holdings Inc., BioClinica Inc., Precision Medicine Group LLC, Worldwide Clinical Trials LLC, Clinigen Group plc, Evidera Inc., Advarra LLC, Veristat LLC, Clinipace Inc., Celonic AG, Cromsource Inc., Novotech Pty Ltd., MedSource Holdings Inc., Frontage Laboratories Inc.

North America was the largest region in the cell and gene therapy clinical trial services market in 2024. It is expected to be the fastest-growing region in the forecast period. The regions covered in the cell and gene therapy clinical trial services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cell and gene therapy clinical trial services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cell and gene therapy clinical trial services market includes revenues earned by providing services, such as regulatory pathways navigation, logistics management, patient retention strategy management, and biomarker analysis services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell And Gene Therapy Clinical Trial Services Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cell and gene therapy clinical trial services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cell and gene therapy clinical trial services ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cell and gene therapy clinical trial services market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Service: Clinical Trial Design And Planning; Supply And Logistic Services; Regulatory Affairs And Compliance; Data Management And Biostatics; Site Management And Monitoring; Other Services
2) By Therapy Type: Gene Therapy; Cell Therapy; Gene Modified Cell Therapy
3) By Indication: Oncology; Hematology; Metabolic Disorders; Infectious Diseases; Neurology; Cardiovascular Diseases; Musculoskeletal Disorders; Other Indications
4) By End-Use: Pharmaceutical And Biotechnology Companies; Contract Research Organizations; Academic And Research Institutes; Other End-Users
Subsegments:
1) By Clinical Trial Design And Planning: Protocol Development; Trial Feasibility Studies; Trial Design Consultation; Patient Recruitment And Enrollment Strategy; Risk-Based Monitoring Plans
2) By Supply And Logistic Services: Clinical Trial Supply Chain Management; Cold Chain Logistics; Packaging And Labeling Services; Transportation And Distribution Of Biological Samples; Customs And Import/Export Services
3) By Regulatory Affairs And Compliance: Regulatory Strategy And Consulting; Regulatory Submission And Documentation; Compliance With GMP (Good Manufacturing Practices); Regulatory Pathway Consultation; Clinical Trial Applications (CTAs)
4) By Data Management And Biostatistics: Clinical Data Management (CDM); Statistical Analysis And Reporting; Clinical Data Monitoring; Data Integration And Validation; Electronic Data Capture (EDC) Solutions
5) By Site Management And Monitoring: Site Selection And Initiation; Clinical Monitoring And Site Visits; Patient Recruitment And Retention; Site Training And Support; Site Performance Monitoring
6) By Other Services: Patient Advocacy And Engagement; Real-World Evidence (RWE) Studies; Post-Trial Services; Medical Writing And Documentation; Clinical Trial Auditing And Inspection
Companies Mentioned: Thermo Fisher Scientific Inc.; Sharp Services LLC; IQVIA; Laboratory Corporation of America Holdings; ICON plc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r29746

1. Executive Summary

2. Cell And Gene Therapy Clinical Trial Services Market Characteristics

3. Cell And Gene Therapy Clinical Trial Services Market Trends And Strategies

4. Cell And Gene Therapy Clinical Trial Services Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Cell And Gene Therapy Clinical Trial Services Growth Analysis And Strategic Analysis Framework

5.1. Global Cell And Gene Therapy Clinical Trial Services PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Cell And Gene Therapy Clinical Trial Services Market Growth Rate Analysis
5.4. Global Cell And Gene Therapy Clinical Trial Services Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Cell And Gene Therapy Clinical Trial Services Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Cell And Gene Therapy Clinical Trial Services Total Addressable Market (TAM)

6. Cell And Gene Therapy Clinical Trial Services Market Segmentation

6.1. Global Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Clinical Trial Design And Planning
Supply And Logistic Services
Regulatory Affairs And Compliance
Data Management And Biostatics
Site Management And Monitoring
Other Services
6.2. Global Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Gene Therapy
Cell Therapy
Gene Modified Cell Therapy
6.3. Global Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oncology
Hematology
Metabolic Disorders
Infectious Diseases
Neurology
Cardiovascular Diseases
Musculoskeletal Disorders
Other Indications
6.4. Global Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmaceutical And Biotechnology Companies
Contract Research Organizations
Academic And Research Institutes
Other End-Users
6.5. Global Cell And Gene Therapy Clinical Trial Services Market, Sub-Segmentation Of Clinical Trial Design And Planning, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Protocol Development
Trial Feasibility Studies
Trial Design Consultation
Patient Recruitment And Enrollment Strategy
Risk-Based Monitoring Plans
6.6. Global Cell And Gene Therapy Clinical Trial Services Market, Sub-Segmentation Of Supply And Logistic Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Clinical Trial Supply Chain Management
Cold Chain Logistics
Packaging And Labeling Services
Transportation And Distribution Of Biological Samples
Customs And Import/Export Services
6.7. Global Cell And Gene Therapy Clinical Trial Services Market, Sub-Segmentation Of Regulatory Affairs And Compliance, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Regulatory Strategy And Consulting
Regulatory Submission And Documentation
Compliance With GMP (Good Manufacturing Practices)
Regulatory Pathway Consultation
Clinical Trial Applications (CTAs)
6.8. Global Cell And Gene Therapy Clinical Trial Services Market, Sub-Segmentation Of Data Management And Biostatistics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Clinical Data Management (CDM)
Statistical Analysis And Reporting
Clinical Data Monitoring
Data Integration And Validation
Electronic Data Capture (EDC) Solutions
6.9. Global Cell And Gene Therapy Clinical Trial Services Market, Sub-Segmentation Of Site Management And Monitoring, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Site Selection And Initiation
Clinical Monitoring And Site Visits
Patient Recruitment And Retention
Site Training And Support
Site Performance Monitoring
6.10. Global Cell And Gene Therapy Clinical Trial Services Market, Sub-Segmentation Of Other Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Patient Advocacy And Engagement
Real-World Evidence (RWE) Studies
Post-Trial Services
Medical Writing And Documentation
Clinical Trial Auditing And Inspection

7. Cell And Gene Therapy Clinical Trial Services Market Regional And Country Analysis

7.1. Global Cell And Gene Therapy Clinical Trial Services Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Cell And Gene Therapy Clinical Trial Services Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cell And Gene Therapy Clinical Trial Services Market

8.1. Asia-Pacific Cell And Gene Therapy Clinical Trial Services Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cell And Gene Therapy Clinical Trial Services Market

9.1. China Cell And Gene Therapy Clinical Trial Services Market Overview
9.2. China Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cell And Gene Therapy Clinical Trial Services Market

10.1. India Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cell And Gene Therapy Clinical Trial Services Market

11.1. Japan Cell And Gene Therapy Clinical Trial Services Market Overview
11.2. Japan Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cell And Gene Therapy Clinical Trial Services Market

12.1. Australia Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cell And Gene Therapy Clinical Trial Services Market

13.1. Indonesia Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cell And Gene Therapy Clinical Trial Services Market

14.1. South Korea Cell And Gene Therapy Clinical Trial Services Market Overview
14.2. South Korea Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cell And Gene Therapy Clinical Trial Services Market

15.1. Western Europe Cell And Gene Therapy Clinical Trial Services Market Overview
15.2. Western Europe Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cell And Gene Therapy Clinical Trial Services Market

16.1. UK Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cell And Gene Therapy Clinical Trial Services Market

17.1. Germany Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cell And Gene Therapy Clinical Trial Services Market

18.1. France Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cell And Gene Therapy Clinical Trial Services Market

19.1. Italy Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cell And Gene Therapy Clinical Trial Services Market

20.1. Spain Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cell And Gene Therapy Clinical Trial Services Market

21.1. Eastern Europe Cell And Gene Therapy Clinical Trial Services Market Overview
21.2. Eastern Europe Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cell And Gene Therapy Clinical Trial Services Market

22.1. Russia Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cell And Gene Therapy Clinical Trial Services Market

23.1. North America Cell And Gene Therapy Clinical Trial Services Market Overview
23.2. North America Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cell And Gene Therapy Clinical Trial Services Market

24.1. USA Cell And Gene Therapy Clinical Trial Services Market Overview
24.2. USA Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cell And Gene Therapy Clinical Trial Services Market

25.1. Canada Cell And Gene Therapy Clinical Trial Services Market Overview
25.2. Canada Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cell And Gene Therapy Clinical Trial Services Market

26.1. South America Cell And Gene Therapy Clinical Trial Services Market Overview
26.2. South America Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cell And Gene Therapy Clinical Trial Services Market

27.1. Brazil Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cell And Gene Therapy Clinical Trial Services Market

28.1. Middle East Cell And Gene Therapy Clinical Trial Services Market Overview
28.2. Middle East Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cell And Gene Therapy Clinical Trial Services Market

29.1. Africa Cell And Gene Therapy Clinical Trial Services Market Overview
29.2. Africa Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cell And Gene Therapy Clinical Trial Services Market Competitive Landscape And Company Profiles

30.1. Cell And Gene Therapy Clinical Trial Services Market Competitive Landscape
30.2. Cell And Gene Therapy Clinical Trial Services Market Company Profiles
- 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Sharp Services LLC Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. IQVIA Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. ICON plc Overview, Products and Services, Strategy and Financial Analysis

31. Cell And Gene Therapy Clinical Trial Services Market Other Major And Innovative Companies

31.1. Syneos Health Inc.
31.2. Catalent Pharma Solutions Inc.
31.3. Charles River Laboratories International Inc.
31.4. Parexel International Corporation
31.5. PRA Health Sciences Inc.
31.6. Covance Inc.
31.7. Medpace Holdings Inc.
31.8. BioClinica Inc.
31.9. Precision Medicine Group LLC
31.10. Worldwide Clinical Trials LLC
31.11. Clinigen Group plc
31.12. Evidera Inc.
31.13. Advarra LLC
31.14. Veristat LLC
31.15. Clinipace Inc.

32. Global Cell And Gene Therapy Clinical Trial Services Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cell And Gene Therapy Clinical Trial Services Market

34. Recent Developments In The Cell And Gene Therapy Clinical Trial Services Market

35. Cell And Gene Therapy Clinical Trial Services Market High Potential Countries, Segments and Strategies

35.1 Cell And Gene Therapy Clinical Trial Services Market In 2029 - Countries Offering Most New Opportunities
35.2 Cell And Gene Therapy Clinical Trial Services Market In 2029 - Segments Offering Most New Opportunities
35.3 Cell And Gene Therapy Clinical Trial Services Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer